Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

Summary

In this study, patients with hepatocellular carcinoma were used as the research object to explore the effectiveness and safety of idarubicin hepatic artery perfusion combined with lipiodol embolization, and to preliminarily explore the possibility of idarubicin in the treatment of hepatocellular carcinoma. Provide evidence-based medicine for the discovery of better TACE combined chemotherapy regimens for the treatment of hepatocellular carcinoma.

Timeline

Start

2021-10

Primary completion

2022-10

Completion

2023-04

Drugs

Indications